Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| JAMP IMIPRAMINE | JAMP PHARMA CORPORATION | Actual shortage | 75MG | Updated Report | 2025-12-25 | 270981 |
| JAMP IMIPRAMINE | JAMP PHARMA CORPORATION | Actual shortage | 10MG | Updated Report | 2025-12-25 | 270978 |
| JAMP GLICLAZIDE-MR | JAMP PHARMA CORPORATION | Actual shortage | 60MG | Updated Report | 2025-12-25 | 246770 |
| JAMP BRIMONIDINE/TIMOLOL | JAMP PHARMA CORPORATION | Actual shortage | 0.2% 0.5% | Updated Report | 2025-12-25 | 270956 |
| PRO-CLONAZEPAM | PRO DOC LIMITEE | Anticipated shortage | 0.5MG | Updated Report | 2025-12-24 | 261296 |
| PRO-CLONAZEPAM | PRO DOC LIMITEE | Actual shortage | 2MG | Updated Report | 2025-12-24 | 261304 |
| PRO-CLONAZEPAM | PRO DOC LIMITEE | Actual shortage | 1MG | Updated Report | 2025-12-24 | 261301 |
| NAT-OSELTAMIVIR | NATCO PHARMA (CANADA) INC | Anticipated shortage | 6MG | Updated Report | 2025-12-24 | 274981 |
| MYTOLAC | ADVANZ PHARMA CANADA INC. | Actual shortage | 120MG | New Report | 2025-12-24 | 274972 |
| MYTOLAC | ADVANZ PHARMA CANADA INC. | Actual shortage | 90MG | New Report | 2025-12-24 | 274969 |
| MYTOLAC | ADVANZ PHARMA CANADA INC. | Actual shortage | 60MG | Updated Report | 2025-12-24 | 274912 |
| MAGNESIUM SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 500MG | Updated Report | 2025-12-23 | 271349 |
| CYSTADANE | RECORDATI RARE DISEASES CANADA INC | Anticipated shortage | 1G | Updated Report | 2025-12-23 | 274961 |
| PMS-COLCHICINE | PHARMASCIENCE INC | Resolved | 0.6MG | Updated Report | 2025-12-23 | 237385 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Actual shortage | 80MG | Updated Report | 2025-12-23 | 272068 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Actual shortage | 60MG | Updated Report | 2025-12-23 | 264180 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Actual shortage | 50MG | Updated Report | 2025-12-23 | 272058 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Actual shortage | 40MG | Updated Report | 2025-12-23 | 272053 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Anticipated shortage | 30MG | New Report | 2025-12-23 | 274941 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Resolved | 30MG | Updated Report | 2025-12-23 | 272047 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Actual shortage | 20MG | Updated Report | 2025-12-23 | 272044 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Anticipated shortage | 15MG | Updated Report | 2025-12-23 | 272039 |
| PMS-METHYLPHENIDATE CR | PHARMASCIENCE INC | Actual shortage | 10MG | Updated Report | 2025-12-23 | 272036 |
| APO-TRAVOPROST-TIMOP PQ | APOTEX INC | Actual shortage | 0.5% 0.004% | Updated Report | 2025-12-23 | 269332 |
| ELLA | LABORATOIRE HRA PHARMA | Resolved | 30MG | Updated Report | 2025-12-23 | 273839 |
| CLOPIDOGREL | SANIS HEALTH INC | Actual shortage | 75MG | Updated Report | 2025-12-23 | 269922 |
| THIAMIJECT INJECTION - LIQ IM IV 100MG/ML | OMEGA LABORATORIES LIMITED | Actual shortage | 100MG | Updated Report | 2025-12-23 | 272785 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | HIKMA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2025-12-23 | 251173 |
| LEVOFLOXACIN IN 5% DEXTROSE INJECTION | HIKMA CANADA LIMITED | Resolved | 5MG | Updated Report | 2025-12-23 | 248804 |
| CYANOCOBALAMIN INJECTION USP | HIKMA CANADA LIMITED | Resolved | 1000MCG | Updated Report | 2025-12-23 | 242881 |
| JAMP-SIMVASTATIN | JAMP PHARMA CORPORATION | Resolved | 20MG | Updated Report | 2025-12-23 | 267597 |
| JAMP LEUCOVORIN | JAMP PHARMA CORPORATION | Resolved | 5MG | Updated Report | 2025-12-23 | 270984 |
| SOLYSTAT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Actual shortage | 250MG | Updated Report | 2025-12-23 | 274875 |
| OTIXAL | MEDEXUS PHARMACEUTICALS INC. | Actual shortage | 0.3% 0.025% | Updated Report | 2025-12-23 | 274572 |
| MYLAN-VALACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 1000MG | Updated Report | 2025-12-23 | 273002 |
| ETOMIDATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 2MG | Updated Report | 2025-12-23 | 273806 |
| DEXAMETHASONE OMEGA UNIDOSE | OMEGA LABORATORIES LIMITED | Actual shortage | 10MG | Updated Report | 2025-12-23 | 274514 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Anticipated shortage | 2MG | Updated Report | 2025-12-22 | 274903 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Anticipated shortage | 2MG | Updated Report | 2025-12-22 | 274900 |
| DEXAMETHASONE-OMEGA | OMEGA LABORATORIES LIMITED | Actual shortage | 4MG | Updated Report | 2025-12-22 | 272781 |
| !T3 IFEX | BAXTER CORPORATION | Anticipated shortage | 1G | Updated Report | 2025-12-22 | 273126 |
| !T3 IFEX | BAXTER CORPORATION | Anticipated shortage | 3G | Updated Report | 2025-12-22 | 273129 |
| JAMP-DOMPERIDONE | JAMP PHARMA CORPORATION | Actual shortage | 10MG | Updated Report | 2025-12-22 | 270962 |
| KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION | CURIUM CANADA INC | Actual shortage | 1MG | Updated Report | 2025-12-22 | 274074 |
| MICRO I | SANDOZ CANADA INCORPORATED | Actual shortage | 100MCG | Updated Report | 2025-12-22 | 274880 |
| VITAMIN K1 | SANDOZ CANADA INCORPORATED | Resolved | 10MG | Updated Report | 2025-12-22 | 273058 |
| INSTILLAGEL | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Actual shortage | 0.05% 2% | Updated Report | 2025-12-22 | 272845 |
| SANDOZ TRAVOPROST | SANDOZ CANADA INCORPORATED | Actual shortage | 0.004% | New Report | 2025-12-22 | 274869 |
| PROTAMINE SULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Actual shortage | 10MG | New Report | 2025-12-22 | 274865 |
| SANDOZ PIRFENIDONE TABLETS | SANDOZ CANADA INCORPORATED | Actual shortage | 267MG | New Report | 2025-12-22 | 274862 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| HUMATROPE | ELI LILLY CANADA INC | Discontinued | 6MG 3.15ML | Updated Report | 2025-12-24 | 240676 |
| HUMATROPE | ELI LILLY CANADA INC | Discontinued | 12MG 3.15ML | Updated Report | 2025-12-24 | 240679 |
| HUMATROPE | ELI LILLY CANADA INC | Discontinued | 24MG 3.15ML | Updated Report | 2025-12-24 | 240682 |
| EMERADE | BAUSCH HEALTH, CANADA INC. | Discontinued | 0.3MG | Updated Report | 2025-12-20 | 274742 |
| EMERADE | BAUSCH HEALTH, CANADA INC. | Discontinued | 0.5MG | Updated Report | 2025-12-20 | 274745 |
| DILANTIN-30 SUSPENSION | BGP PHARMA ULC | Discontinued | 30MG | New Report | 2025-12-19 | 274803 |
| DILANTIN-125 SUSPENSION | BGP PHARMA ULC | Discontinued | 125MG | New Report | 2025-12-19 | 274800 |
| GRAVOL IM | CHURCH & DWIGHT CANADA CORP | Discontinued | 50MG | Updated Report | 2025-12-19 | 274712 |
| ELOCOM | ORGANON CANADA INC. | To be discontinued | 0.1% | Updated Report | 2025-12-18 | 272684 |
| VESICARE | ASTELLAS PHARMA CANADA INC | Discontinued | 5MG | Updated Report | 2025-12-18 | 274465 |
| VESICARE | ASTELLAS PHARMA CANADA INC | Discontinued | 10MG | Updated Report | 2025-12-18 | 274468 |
| SAG-M | HAEMONETICS CORPORATION | To be discontinued | 0.525% 0.9% 0.877% 0.0169% | Updated Report | 2025-12-17 | 259444 |
| TARO-CLOBETASOL OINTMENT USP, 0.05% | TARO PHARMACEUTICALS INC | Discontinued | 0.05% | Updated Report | 2025-12-13 | 274315 |
| CEFTRIAXONE SODIUM FOR INJECTION BP | STERIMAX INC | To be discontinued | 250MG | New Report | 2025-12-11 | 274173 |
| BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | STERIMAX INC | To be discontinued | 7.5MG | New Report | 2025-12-11 | 274162 |
| TRUSOPT | ELVIUM LIFE SCIENCES | Discontinued | 2% | Updated Report | 2025-12-10 | 267941 |
| FIASP | NOVO NORDISK CANADA INC | Discontinued | 100UNIT | Updated Report | 2025-12-08 | 240240 |
| NAT-LEVETIRACETAM | NATCO PHARMA (CANADA) INC | Discontinued | 500MG | Updated Report | 2025-12-06 | 273434 |
| NAT-LEVETIRACETAM | NATCO PHARMA (CANADA) INC | Discontinued | 750MG | Updated Report | 2025-12-06 | 273437 |
| NAT-OMEPRAZOLE DR | NATCO PHARMA (CANADA) INC | Discontinued | 20MG | Updated Report | 2025-12-06 | 273440 |

